Indivior Pharmaceuticals Inc
INDV
주식 순위
#4014
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
주가
$32.56
마지막 동기화: 2026-10-16
시가총액
$4.06B
변동 (1일)
-3.15%
변동 (1년)
33.01%
국가
US
거래 Indivior Pharmaceuticals Inc (INDV)
카테고리
Healthcare
Indivior Pharmaceuticals Inc (INDV)의 EPS
June 2026 기준 EPS TTM: $2.84
Indivior Pharmaceuticals Inc의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $2.84입니다. 2023년 말에는 회사의 EPS가 $0.01였으며, 이는 2022년의 EPS $-0.37와 증가입니다.
Indivior Pharmaceuticals Inc의 EPS 기록 (2016 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
